Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma
一项Ib期研究评估了抗PD-L1单克隆抗体索卡唑利单抗联合白蛋白紫杉醇作为晚期尿路上皮癌一线治疗的疗效
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae260
Tang, Bixia; Xiao, Jun; Chi, Zhihong; Duan, Rong; Cui, Chuanliang; Si, Lu; Liu, Yixun; Hu, Xuechun; Liu, Zhi; Xiang, Ping; Li, Siming; Yan, Xieqiao; Zhou, Li; Li, Juan; Li, Yujie; Yu, Xiaohui; Dai, Xiangrong; Li, Xiaoyi; Guo, Jun; Sheng, Xinan